期刊文献+

超敏C-反应蛋白测定在冠心病中的应用 被引量:1

超敏C-反应蛋白测定在冠心病中的应用
下载PDF
导出
摘要 超敏C-反应蛋白(hs-CRP)是一种急性时相反应蛋白,常作为炎症相关疾病的检测指标。冠心病存在慢性炎症过程,检测hs-CRP有助于预测急性冠状动脉事件、评估冠心病的严重程度和观察演变情况,对冠心病患者的临床危险分层有重要参考价值。 Hs-CRP is an acute phase reaction proteins, often used as a detection indicators of inflammation-related diseases.Coronary heart disease is a chronic inflammatory processes,and detecting hs-CRP is helpful for predicting the evolution of acute coronary events, assess the severity of coronary heart disease and observed,and has an important reference value for Clinical risk stratification of patients with coronary heart disease.
作者 周高乐
出处 《科技信息》 2013年第5期465-465,共1页 Science & Technology Information
关键词 HS-CRP 冠心病 炎症过程 hs-CRP Coronary heart disease Inflammatory process
  • 相关文献

参考文献9

  • 1Suleiman M,Khatib R,Agmon Y,et al.Early inflammation and risk of long- term development of heart failure and mortality in survivors of acute myocardial in- farction predictive role of C-reactive protein [J]. J Am Coil Cardiol,2006,47(5): 962-968.
  • 2Arroyo-Espliguero R,Avanzas P,Quil.es J,et al.C-reactive protein predicts functional status and correlates with left ventricular ejection fraction patients with chronic stable angina[J].Atherosclerosis, 2009,205(1) : 319-324.
  • 3Hermann M,Fischer D,Hoffmann MM,et al.CRP and CD14 polymorphisms correlate with coronary plaque volume in patients with coronary artery disease- IVUS substudy of the ENCORE tfials[J].Athemsclerosis, 2012,220(1): 172-176.
  • 4Madsen T,Christensen JH,Toft E,et al.C-reactive protein is associated with heart rate variability[J].Ann Noninvasive Electrocardiot, 2007,12(3) : 216-222.
  • 5Almagor M, Keren A,and Banai S. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease [J]. Am Heart J ,2003,145:248-53.
  • 6Zairs M N, Manousakis S J , Stefanidis A S, et al. C-reactive protein levels on admission are associated with response to thrombolysis and prognosis after ST- segment elevation acute myocardial infarction[J]. Am Heart J ,2002,144:782-9.
  • 7Winter R J, Sanders Heyde G S , Koch K T, et al. The prognostic value of pre - procedural plasma C - reactive protein in patients undergoing elective coro- nary angioplasty[J]. Eur Heart J , 2002,23 : 960-6.
  • 8Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: an in- dependent prognostic factor [J]. Stroke, 2001,32 : 917-24.
  • 9Ridker P M, High-sensitivity C-reactive protein : potential adjunct for global risk assessment in the primary prevention of cardfiovascular disease[J]. Circulation, 2001,103 : 1813-8.

同被引文献13

  • 1FUHRMAN B. The urokinase system in the pathogenesis of atherosclerosis[J]. Atherosclerosis, 2012,222( 1 ) : 8-14.
  • 2PAWLAK K, MYSLIWIEC M, PAWLAK D. The urokinase-type plasminogen activator/its soluble receptor system is independently related to carotid atherosclerosis and associated with CC-chemokines in uraemic patients[J]. Thromb Res, 2008, 122(3) : 328-335.
  • 3SVENSSON P A, OLSON F J type plasminogen activator HAGG D A, et al. Urokinase- receptor is associated with macrophages and plaque rupture in symptomatic carotid atherosclerosis [ J ]. Int J Mol Med, 2008,22 (4) : 459-464.
  • 4HU J I-I, DU L, CHU T, et al. Overexpression of urokinase by plaque macrophages causes histological features of plaque rupture and increases vascular matrix metalloproteinase activity in aged apolipoprotein e-null mice[J]. Circulation, 2010,121 (14) : 1637-1644.
  • 5FARRIS S D, HU J H, KRISHNAN R, et al. Mechanisms of urokinase plasminogen activator ( uPA ) -mediated atheroselerosis: role of the aPA receptor and SIOOA8/A9 proteins [ J ]. J Biol Chem, 2011,286 (25) : 22665-22677.
  • 6STEPANOVA V, LEBEDEVA T, KUO A, et al. Nuclear translocation of urokinase-type plasminogen activator [ J ]. Blood, 2008,112(1): 100-110.
  • 7REICHEL C A, KANSE S M, KROMBACH F. At theinterface of fibrinolysis and inflammation : the role of urokinase- type plasminogen activator in the leukocyte extravasation cascade[J]. Trends Cardiovasc Med, 2012, 22(7): 192-196.
  • 8PLEKHANOVA O, BERK B C, BASHTRYKOV P, et al. Oligonucleotide microarrays reveal regulated genes related to inward arterial remodeling induced by urokinase plasminogen activator[J]. J Vase Res, 2009, 46(3) : 177-187.
  • 9MINAMI E, CASTELLANI C, MALCHODI L, et al. The role of maerophage-derived urokinase plasminogen activator in myocardial infarct repair: urokinase attenuates ventricular remodeling[J]. J Mol Cell Cardiol, 2010,49(3): 516-524.
  • 10TKACHUK V A, PLEKHANOVA O S, PARFYONOVA Y V. Regulation of arterial remodeling and angiogenesis by urokinase- type plasminogen activator[J].Can J Physiol Pharmacol, 2009, 87(4) : 231-251.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部